image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

  2022 2021 2020 2019 2018

Year wise published articles

105 141 28 8 28

Year wise citations received

543 553 590 563 587
Journal total citations count 6601
Journal Impact Factor 6.49
Journal 5 years Impact Factor 12.17
Journal CiteScore 11.19
Journal h-index 41
Journal h-index since 2016 26
Demmin, Docia L., Samantha I. Fradkin, and Steven M. Silverstein. "Remediation of visual processing impairments in schizophrenia: where we are and where we need to be." Current Behavioral Neuroscience Reports 6, no. 2 (2019): 13-20.
Okbay, Aysu, Bart ML Baselmans, Jan-Emmanuel De Neve, Patrick Turley, Michel G. Nivard, Mark Alan Fontana, S. Fleur W. Meddens et al. "Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses." Nature genetics 48, no. 6 (2016): 624-633.
Heringa, Sophie M., Marieke JH Begemann, Angelique J. Goverde, and Iris EC Sommer. "Sex hormones and oxytocin augmentation strategies in schizophrenia: a quantitative review." Schizophrenia research 168, no. 3 (2015): 603-613.
Popova, Petia, Brigitte Rockstroh, Gregory A. Miller, Christian Wienbruch, Almut M. Carolus, and Tzvetan Popov. "The impact of cognitive training on spontaneous gamma oscillations in schizophrenia." Psychophysiology
Nahum, Mor, Hyunkyu Lee, Melissa Fisher, Michael F. Green, Christine I. Hooker, Joseph Ventura, Joshua T. Jordan et al. "Online social cognition training in schizophrenia: a double-blind, randomized, controlled multi-site clinical trial." Schizophrenia bulletin 47, no. 1 (2021): 108-117.
Dorado Ramírez, Carlos Alberto, and Daniela Castaño Correa. "Efectividad de los programas computorizados en rehabilitación cognitiva de pacientes con esquizofrenia." Pensamiento Psicológico 16, no. 2 (2018): 73-86.
Ciruela, Francisco, Víctor Fernández-Dueñas, Xavier Altafaj, Fernando Contreras, Antoni Vallano, José Manuel Menchón, and Marta Valle-León. "The adenosinergic system in the neurobiology of schizophrenia: Prospective adenosine receptor–based pharmacotherapy." In Psychiatry and Neuroscience Update-Vol. II, pp. 405-419. Springer, Cham, 2017.
Millan, Mark J., Kevin Fone, Thomas Steckler, and William P. Horan. "Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment." European Neuropsychopharmacology 24, no. 5 (2014): 645-692.
Pratt, Judith, Catherine Winchester, Neil Dawson, and Brian Morris. "Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap." Nature reviews Drug discovery 11, no. 7 (2012): 560-579.
Ciruela, Francisco, Víctor Fernández-Dueñas, Fernando Contreras, Josep M. Arnau, José Manuel Menchón, Antoni Vallano, and Marta Valle-León. "Adenosine in the neurobiology of schizophrenia: potential adenosine receptor-based pharmacotherapy." In Psychiatry and Neuroscience Update, pp. 375-388. Springer, Cham, 2015.
Weidemann, Frank, Maria D. Sanchez-Nino, Juan Politei, João-Paulo Oliveira, Christoph Wanner, David G. Warnock, and Alberto Oritz. "Fibrosis: a key feature of Fabry disease with potential therapeutic implications." Orphanet Journal of Rare Diseases 8, no. 116 (2013).
Seeman, Philip. "All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2High receptors." CNS neuroscience & therapeutics 17, no. 2 (2011): 118-132.
Carr, Chelsea N., Craig M. Straley, and Terrence B. Baugh. "Allopurinol for the treatment of refractory aggression: a case series." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37, no. 6 (2017): 748-754.
Lado-Codesido, María, Cristina Méndez Pérez, Raimundo Mateos, José Manuel Olivares, and Alejandro García Caballero. "Improving emotion recognition in schizophrenia with“ VOICES ”: an on-line prosodic self-training." PloS one 14, no. 1 (2019): e0210816.
Brisch, Ralf, Arthur Saniotis, Rainer Wolf, Hendrik Bielau, Hans-Gert Bernstein, Johann Steiner, Bernhard Bogerts et al. "The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue." Frontiers in psychiatry 5 (2014): 47.
Narita, Zui, Takuma Inagawa, Kazushi Maruo, Kazuki Sueyoshi, and Tomiki Sumiyoshi. "Effect of transcranial direct current stimulation on functional capacity in schizophrenia: a study protocol for a randomized controlled trial." Frontiers in psychiatry 8 (2017): 233.
Hirota, Tomoya, and Taro Kishi. "Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators." Schizophrenia research 149, no. 1-3 (2013): 88-95.
Linke, Magdalena, and Marek Jarema. "Cognitive rehabilitation for people living with schizophrenia — The newest interventions." Psychiatria Polska (2014).
Meltzer, Herbert Y. "Update on typical and atypical antipsychotic drugs." Annual review of medicine 64 (2013): 393-406.
Trojsi, Francesca, Mattia Siciliano, Antonio Russo, Carla Passaniti, Cinzia Femiano, Teresa Ferrantino, Stefania De Liguoro et al. "Theory of mind and its neuropsychological and quality of life correlates in the early stages of amyotrophic lateral sclerosis." Frontiers in psychology 7 (2016): 1934.